home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Genetic News | search  
 

Focus On Natural Killer Cells

 
  May, 1 2008 8:53
your information resource in human molecular genetics
 
     
Enormous progress has been made recently in understanding natural killer (NK) cells - a group of immune cells with diverse biological functions and wide ranging therapeutic potential. A series of articles in Nature Immunology explore the behaviour of these enigmatic lymphocytes and reflect on their transition from outcasts of mainstream immunology to prominent players in innate immunity.

In a Review article, Eric Vivier makes the case that although originally identified as capable of killing tumour cells in culture dishes, NK cells are now established as playing important roles in eliminating pathogens, 'steering' the course of immune responses and facilitating fetus implantation during pregnancy. Laurence Zitvogel emphasizes in a Perspective article that much more clinical work is needed to translate this knowledge of NK cell function into efficacious therapies for autoimmune diseases and cancer.

Lewis Lanier discusses the mechanisms through which NK cells manage to respond to pathogens and tumour cells yet remain tolerant to healthy 'self' cells thereby preventing the cells from inducing autoimmunity. Klas Karre recounts his seminal work on the same topic in an Essay.

Finally Jim Di Santo overviews the 'top ten' outstanding questions in NK cell biology, and Wayne Yokoyama highlights experimental pitfalls that should be avoided by those seeking to answer these questions.

Together with the articles online, the Focus includes links to seminal papers nominated by experts; recent papers in the field published by Nature Publishing Group, and highlights of recent studies that present new insight into NK cell biology.

Author contacts:

Eric Vivier (Universite la Mediterranee, Marseille, France)
E-mail: vivier@ciml.univ-mrs.fr
Paper [1]

Laurence Zitvogel (INSERM, Institut Gustave Roussy, Paris, France)
E-mail: zitvogel@igr.fr
Paper [2]

Lewis Lanier (University of California, San Francisco, CA, USA)
E-mail: lewis.lanier@ucsf.edu
Paper [3]

Klas Karre (Karolinska Institutet, Stockholm, Sweden)
E-mail: klas.karre@ki.se
Paper [4]

James Di Santo (INSERM, Institut Pasteur, Paris, France)
E-mail: disanto@pasteur.fr
Paper [5]

Wayne Yokoyama (Washington University School of Medicine, St. Louis, MO, USA)
E-mail: yokoyama@im.wustl.edu
Paper [6]

(C) Nature Immunology press release.


Message posted by: Trevor M. D'Souza

print this article mail this article
Bookmark and Share this page (what is this?)

Social bookmarking allows users to save and categorise a personal collection of bookmarks and share them with others. This is different to using your own browser bookmarks which are available using the menus within your web browser.

Use the links below to share this article on the social bookmarking site of your choice.

Read more about social bookmarking at Wikipedia - Social Bookmarking

Latest News
Variants Associated with Pediatric Allergic Disorder

Mutations in PHF6 Found in T-Cell Leukemia

Genetic Risk Variant for Urinary Bladder Cancer

Antibody Has Therapeutic Effect on Mice with ALS

Regulating P53 Activity in Cancer Cells

Anti-RNA Therapy Counters Breast Cancer Spread

Mitochondrial DNA Diversity

The Power of RNA Sequencing

‘Pro-Ageing' Therapy for Cancer?

Niche Genetics Influence Leukaemia

Molecular Biology: Clinical Promise for RNA Interference

Chemoprevention Cocktail for Colon Cancer

more news ...

Generated by News Editor 2.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2017 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.